AbbVie shares drop 5.5% after short seller Citron calls it 'next

AbbVie shares drop 5.5% after short seller Citron calls it 'next great drug short'

Emma Court

,

MarketWatch•July 19, 2018

 

 

AbbVie Inc. (ABBV) shares dropped 5.5% in heavy Thursday morning trade after short seller Citron Research described the company as "the next great drug short" in a tweet and said it planned to release reports about the company. The Citron tweet came the day after Food and Drug Administration Commissioner Scott Gottlieb put out a plan to encourage the development and uptake of lower-priced biosimilar drugs, accusing large drugmakers in a speech of stymying the competition. The short seller also predicted that AbbVie shares, which closed at $94.40 on Wednesday, would drop to $60.

所有跟帖： 

• 被大熊盯上了！ -Tiger666- ♂ (0 bytes) () 07/19/2018 postreply 07:45:28

• ABBV 4% div，前两天买入半仓，等被逼下70再加仓，看Citron是否有能耐 -周末闲语- ♂ (37 bytes) () 07/19/2018 postreply 08:17:04